The deal values Shockwave stock at $335 per share and is expected to close in mid-2024. Johnson & Johnson says the transaction will be slightly dilutive to its adjusted earnings this year and next. Adding Shockwave Medical will further expand J&J medtech's expertise in cardiovascular intervention.
Will Shockwave medical stock close in 2024?
On , Shockwave Medical shares rose 2% to 326.34, while J&J stock fell a fraction to 152.39. The deal values Shockwave stock at $335 per share and is expected to close in mid-2024. Johnson & Johnson says the transaction will be slightly dilutive to its adjusted earnings this year and next.
Will Johnson & Johnson buy Shockwave?
Under the terms of the agreement, Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash through a merger of Shockwave with a wholly owned Johnson & Johnson subsidiary. Johnson & Johnson expects to fund the transaction through a combination of cash on hand and debt.
